Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia

Abstract

With this set of studies, we demonstrate that impairment of AHR signalling contributes to hepatic inflammatory and metabolic disorders characterizing cancer cachexia, paving the way for innovative therapeutic strategies in this context.